Skip to main content

Table 4 Differences between the groups regarding access to clinical trials and cultural specific information

From: Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

  NM FGM SGM/TGM p-value
Offered a clinical trail 216 (50.7%) 29 (28.4%) 34 (56.7%) < 0.05
Participated in a clinical trail 144 (33.5%) 16 (15.7%) 28 (47.5%) < 0.05
Offered alternative therapies 162 (39.0%) 37 (37.4%) 27 (48.2%) 0.37
Participated in follow-up care 372 (91.0%) 91 (89.2%) 53 (94.6%) 0.25
Contacted a support group 79 (18.5%) 11 (10.8%) 13 (21.7%) 0.12
Aware of information materials in their preferred language 247 (60.8%) 19 (18.6%) 37 (69.8%) < 0.05